搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug (April 30)
Reuters· 46 分鐘前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
U.S., allies press UAE over Russia trade, sanctions
Reuters· 21 小時前The United States, Britain and the European Union are pressing the United Arab Emirates to show ...
US surgeon in Gaza: nothing prepared me for scale of injuries
Reuters· 23 小時前A U.S. vascular surgeon who left Gaza after a stint as a volunteer said nothing had prepared ...
Walmart to shut all health clinics in US over lack of profitability
Reuters· 24 小時前, opens new tab said on Tuesday it will close all 51 of its health clinics and shut its virtual ...
UK's Domino's Pizza sees slow start in second quarter
Reuters· 1 日前, opens new tab said on Wednesday the second quarter started off slower due to a stronger ...
Book Review: Joseph Epstein’s Excellent ‘Never Say You’ve Had a Lucky Life’
Forbes· 1 日前In my imagining, Epstein grew up in a house full of deep conversations about big ideas, that he ...
How Climate Change Activists Undermine The Energy Transition
Forbes· 1 日前There is a public perception, partly justified, that fossil fuel producers are attempting to ...
McDonald's posts rare profit miss as customers turn picky
Reuters· 1 日前, opens new tab missed quarterly profit estimates for the first time in two years as ...
Wall Street stocks fall as markets weigh strong wage data, Fed meeting
Reuters· 2 日前U.S. stocks ended lower on Tuesday as markets weighed economic data showing rising labor costs ...
How Building A Relationship With AI Can Improve Your Work
Forbes· 2 日前In 1816, 18-year-old Mary Shelley wrote her timeless masterpiece, Frankenstein. Born of a vivid ...